Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008–2013

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 10, 2015, Pages 2131-2136

  Smit, P W ^a,b   Lindholm, L ^b   Lyytikainen O ^b   Jalava, J ^b   Patari Sampo A ^c   Vuopio, J ^b,d  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BLOOD; CEREBROSPINAL FLUID; CHILD; CLONAL VARIATION; FATALITY; FEMALE; FINLAND; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INVASIVE GROUP A STREPTOCOCCAL INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REGISTER; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; STREPTOCOCCAL INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84941425441     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2462-2     Document Type: Article

References (24)

1. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A et al (2014) Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev 27:264–301. doi:10.1128/CMR.00101-13
2. Darenberg J, Henriques-Normark B, Lepp T, Tegmark-Wisell K, Tegnell A, Widgren K (2013) Increased incidence of invasive group A streptococcal infections in Sweden, January 2012–February 2013. Euro Surveill 18:pii=20443. Available online at: http://www.eurosurveillance.eu/images/dynamic/EE/V18N14/art20443.pdf
3. Syrogiannopoulos GA, Grivea IN, Al-Lahham A, Panagiotou M, Tsantouli AG, Michoula Ralf René Reinert AN et al (2013) Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. PLoS One 8:e71558. doi:10.1371/journal.pone.0071558
4. Vähäkuopus S, Vuento R, Siljander T, Syrjänen J, Vuopio J (2012) Distribution of emm types in invasive and non-invasive group A and G streptococci. Eur J Clin Microbiol Infect Dis 31:1251–1256. doi:10.1007/s10096-011-1436-2
5. Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J (2010) Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis 29:1229–1235. doi:10.1007/s10096-010-0989-9
6. Rantala S, Vähäkuopus S, Siljander T, Vuopio J, Huhtala H, Vuento R et al (2012) Streptococcus pyogenes bacteraemia, emm types and superantigen profiles. Eur J Clin Microbiol Infect Dis 31:859–865. doi:10.1007/s10096-011-1385-9
7. Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW et al (2014) Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A 111:E1768–E1776. doi:10.1073/pnas.1403138111
8. Deresinski S (2014) Streptococcus pyogenes: the path to enhanced virulence. Clin Infect Dis 59:iii–iv. doi:10.1093/cid/ciu351
9. Aziz RK, Kotb M (2008) Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 14:1511–1517. doi:10.3201/eid1410.071660
10. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K et al (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337:441–446. doi:10.1056/NEJM199708143370701
11. Gunell M, Jalava J (2014) Antimicrobial resistance in Finland- Finres 2012. National stitute for Health and Welfare, Helsinki, Finland. http://urn.fi/URN:ISBN:978-952-302-183-9
12. Siljander T, Karppelin M, Vähäkuopus S, Syrjänen J, Toropainen M, Kere J et al (2008) Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 46:855–861. doi:10.1086/527388
13. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616. doi:10.1016/S1473-3099(09)70178-1
14. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47:1155–1165. doi:10.1128/JCM.02155-08
15. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367. doi:10.1128/JCM.00422-08
16. Meehan M, Murchan S, Bergin S, O’Flanagan D, Cunney R (2013) Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013. Euro Surveill 18:20556. http://www.ncbi.nlm.nih.gov/pubmed/23968875
17. Guy R, Williams C, Irvine N, Reynolds A, Coelho J, Saliba V et al (2014) Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill 19:20749. doi: 10.2807/1560-7917.ES2014.19.12.20749
18. Olafsdottir LB, Erlendsdóttir H, Melo-Cristino J, Weinberger DM, Ramirez M, Kristinsson KG et al (2014) Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012. Euro Surveill 19:5–15. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20784
19. Turner CE, Abbott J, Lamagni T, Holden MTG, David S, Jones MD et al (2015) Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. MBio 6:e00622-15. doi:10.1128/mBio.00622-15
20. Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J (2009) Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 47:477–480. doi:10.1128/JCM.01663-08
21. Meisal R, Andreasson IKG, Høiby EA, Aaberge IS, Michaelsen TE, Caugant DA (2010) Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol 48:842–851. doi:10.1128/JCM.01312-09
22. Douthwaite S, Jalava J, Jakobsen L (2005) Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol Microbiol 58:613–622. doi:10.1111/j.1365-2958.2005.04863.x
23. Pesola AK, Sihvonen R, Lindholm L, Pätäri-Sampo A (2015) Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013. Euro Surveill 20. pii: 21117
24. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK (1996) Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 173:896–900